FC
Fred E Cohen

Fred E Cohen insider trades: Intellia Therapeutics (NTLA) stock buys and sales

Intellia Therapeutics Last trade Jan 5, 2026 168 Form 4 filings
$0
Sold, last 12 months
0 sales
$1.4M
Bought, last 12 months
1 buy
10
Open-market trades
since 2017
11
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Fred reports to the SEC

and 5 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 5, 2026NTLA↑ Buy$1.4M
May 18, 2020VCYT↓ Sell$1.1M
Feb 22, 2019GHDX↓ Sell$789K
Nov 8, 2018GHDX↓ Sell$879K
Sep 6, 2018GHDX↓ Sell$507K
Aug 7, 2018GHDX↓ Sell$464K
Sep 18, 2017BCRX↓ Sell$294K
May 19, 2017GHDX↓ Sell$244K
May 18, 2017GHDX↓ Sell$493K
May 16, 2017GHDX↓ Sell$253K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NTLA insiders

Open-market trades in the last 12 months

About Fred E Cohen's insider trades

Fred E Cohen is an insider at Intellia Therapeutics (NTLA). Since May 16, 2017, Fred has reported 1 open-market purchase worth $1.4M and 9 sales worth $5.0M on SEC Form 4. In the last 12 months: 1 buy ($1.4M).

Their filings also include grants and awards (140 filings), option exercises (20 filings), conversions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NTLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.